Cargando…
A Review on Inosine Pranobex Immunotherapy for Cervical HPV-Positive Patients
The purpose of this review was to examine and summarize data for inosine pranobex (IP) immunotherapy in cervical HPV-positive patients. Persistent or recurring cervical human papillomavirus (HPV) infection is a major cause of cervical cancer. Self-clearance and blocking of cervical HPV infection dep...
Autor principal: | Kovachev, Stefan Miladinov |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180272/ https://www.ncbi.nlm.nih.gov/pubmed/34103950 http://dx.doi.org/10.2147/IDR.S296709 |
Ejemplares similares
-
Genotoxicity and Mutagenicity of Inosine Pranobex
por: Tobólska, Sylwia, et al.
Publicado: (2018) -
Inhibition of adenovirus multiplication by inosine pranobex and interferon α in vitro
por: Majewska, Anna, et al.
Publicado: (2016) -
Influence of Inosine Pranobex on Cell Viability in Normal Fibroblasts and Liver Cancer Cells
por: Tobólska, Sylwia, et al.
Publicado: (2018) -
Azithromycin/inosine-pranobex off label use: Lack of efficacy: case report
Publicado: (2022) -
Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course
por: Beran, Jiří, et al.
Publicado: (2021)